Latest Venlafaxine Stories

2008-10-15 09:00:48

COLLEGEVILLE, Pa., Oct. 15 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , today provided an update on its global strategy for desvenlafaxine for the treatment of major depressive disorder (MDD) in adults.

2008-10-09 12:00:39

Osmotica Pharmaceutical Corp. is announcing that Venlafaxine Extended-Release Tablets, 37.5 mg, 75 mg, 150 mg, and 225 mg, which was approved by the U.S. Food and Drug Administration in May, is now commercially available through its marketing partner, Upstate Pharma, LLC, a subsidiary of UCB, Inc.

2008-09-26 09:00:40

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy.

2008-09-23 12:10:00

For some time, antidepressants and other drugs have been used collectively to treat hot flashes and other menopausal symptoms that can accompany breast cancer treatment. However, researchers said on Monday that ancient acupuncture methods work just as well as drugs and their effects tend to outlast drugs.

2008-09-11 03:00:08

By Klinger, Gil Merlob, Paul Abstract: Depression is common in women of childbearing age and especially during pregnancy and the postpartum period. Selective serotonin reuptake inhibitors (SSRIs) are increasingly being used to treat depression prior to and throughout pregnancy.

2008-07-20 03:00:15

By Raymond, Colette B Wazny, Lori D; Honcharik, Patricia L Depressive disorders occur in up to one-third of patients with chronic kidney disease CKD).

2008-07-16 18:00:42

MADISON, N.J., July 16 /PRNewswire-FirstCall/ -- Wyeth and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S.

2008-07-15 09:01:35

WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists' prescribing decisions in the treatment of this disorder.

2008-07-11 12:01:04

By John Sullivan, The Philadelphia Inquirer Jul. 11--Patients taking a popular type of antidepressant are at greater risk for upper gastrointestinal bleeding, according to a new study which appears in the July issue of Archives of General Psychiatry.

Word of the Day
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.